Ipamorelin vs CJC-1295
Two GH-axis compounds, side by side: how each is built, where their chemistry diverges, and what each is kept as a reference standard for. Different mechanisms, frequently studied as a pair.
How They Differ
The real difference is mechanism and structure. Ipamorelin is a five-residue ghrelin-receptor secretagogue, the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, with a molecular weight near 711 daltons. Its character comes from deliberately non-natural building blocks: an N-terminal alpha-aminoisobutyric acid (Aib) cap and two central D-amino acids, D-2-naphthylalanine and D-phenylalanine, which a chemist reads straight off the sequence. It belongs to the GHRP branch of the GH axis, the peptides that engage the ghrelin receptor.
CJC-1295 is a different molecule entirely. It is an analog of GHRH(1-29), the first 29 residues of growth-hormone-releasing hormone, so it sits in the GRF analog branch modeled on a different upstream peptide and acts at a different receptor. Its signature is the optional Drug Affinity Complex (DAC) group, a maleimido-propionyl linker conjugated to a lysine side chain that lets the peptide bind serum albumin. The without-DAC version, often labeled modified GRF(1-29), is the plain 29-residue chain. So the two compounds differ in length, in sequence, in the receptor branch they model, and in their defining modification, the short peptide leaning on D-stereochemistry and an Aib cap, the longer chain leaning on an albumin-binding linker.
Choosing a Reference Standard
For a research chemist, the choice between them is a question of which chemistry the work calls for. Ipamorelin is the cleaner subject when the point is to study how a few non-natural building blocks, a D-residue pair, an Aib cap, and a C-terminal amide, change a short peptide's stability, solubility, and chromatographic behavior. Its brevity makes it a tractable model system and a well characterized reference point when validating synthesis and analytical methods on related secretagogues.
CJC-1295 is the reference of choice when the subject is the GHRH backbone or half-life engineering through conjugation. Its matched with-DAC and without-DAC pair is a clean teaching case for how a single albumin-binding linker changes a peptide's mass, retention, and synthesis route without touching the receptor-binding sequence. In practice the two are not mutually exclusive, because they represent two distinct branches of the same axis, many labs keep both as complementary reference points rather than choosing one over the other. Documentation describing the methods behind each is available on request for the standards we carry.
Kept as a complementary pair
Labs commonly keep both ipamorelin and CJC-1295 on the bench. They are not interchangeable, they are two distinct chemistries within the same axis, a short ghrelin-receptor secretagogue and a longer GHRH analog, which is exactly why they make useful complementary reference points for method work and structural comparison. This is a chemistry and documentation rationale only, not a statement about combined use or any outcome.
This comparison is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Nothing here describes or implies any use of these compounds together or apart in humans or animals, or any outcome. Buyers are responsible for compliance with all applicable laws and regulations.
What is the difference between ipamorelin and CJC-1295?
They are different chemical classes within the GH-axis group. Ipamorelin is a five-residue ghrelin-receptor secretagogue, the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, while CJC-1295 is a GHRH(1-29) analog modeled on growth-hormone-releasing hormone and supplied with or without a DAC albumin-binding linker. They act at different receptors and differ in length, sequence, and modifications, which is exactly why they are read side by side rather than treated as interchangeable.
Are ipamorelin and CJC-1295 in the same class?
Both sit in the broader GH-axis catalog, but in different branches. Ipamorelin belongs to the growth-hormone secretagogue (GHRP) branch that acts at the ghrelin receptor, while CJC-1295 belongs to the GRF analog branch modeled on GHRH. They are grouped together as a research family because they are studied with the same synthetic and analytical methods, not because they share a mechanism.
How are ipamorelin and CJC-1295 synthesized?
Both are assembled by Fmoc solid-phase peptide synthesis and characterized with reversed-phase HPLC for the purity figure and mass spectrometry for identity. The chemistry differs in scale: ipamorelin is a short five-residue chain with non-natural and D-configured building blocks, while CJC-1295 is a 29-residue chain whose with-DAC form adds a separate linker-conjugation step.
Should a lab keep both ipamorelin and CJC-1295 on the bench?
They are frequently studied as a pair, so many labs keep both as complementary reference standards. Because they represent two distinct chemistries within the same axis, a short ghrelin-receptor secretagogue and a longer GHRH analog, having both on hand gives a research chemist matched reference points for method validation and structural comparison. This is a chemistry and documentation rationale only and is not a statement about combined use or any outcome.
Are ipamorelin and CJC-1295 for research use only?
Yes. Both are supplied as reference standards for laboratory and research use only. They are not for human or veterinary consumption, and nothing here describes or implies any such use. Buyers are responsible for compliance with all applicable laws and regulations.